Centiva Capital, LP Qiagen N.V. Transaction History

Centiva Capital, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$45.29 - $50.76 $401,541 - $450,038	8,866 New	8,866 $407,000
Q2 2022 Aug 15, 2022	SELL	$42.98 - $49.77 $337,736 - $391,092	-7,858 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$42.23 - $54.3 $331,843 - $426,689	7,858 New	7,858 $385,000
Q4 2020 Feb 16, 2021	SELL	$46.09 - $54.74 $1.44 Million - $1.71 Million	-31,200 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$42.51 - $52.42 $950,353 - $1.17 Million	22,356 Added 252.78%	31,200 $1.63 Million

Q2 2020 Aug 14, 2020	BUY	$39.49 - $44.36 $349,249 - $392,319	8,844 New	8,844 $379,000
Q1 2020 May 15, 2020	SELL	$33.17 - $41.6 $331,700 - $416,000	-10,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$25.41 - $43.1 $254,100 - $431,000	10,000 New	10,000 $338,000

6.76M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.16B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.